Connect with us

Emerging Markets

Life Clips Inc (OTCMKTS: LCLP) Running Northbound after Crypto Co announces Subsidiary Belfrics Goes Live Offering Crypto Derivatives and Leveraged Forex Instruments

Published

on

Life Clips Inc (OTCMKTS: LCLP) is making a powerful move up the charts after the Company reported its wholly owned subsidiary Belfrics International Limited (Labuan) Malaysia, which holds a money broker license from Labuan Financial Services Authority, will go live offering Leveraged Forex Instruments and Crypto Derivative Contracts to its customers on Saturday, October 2, 2021. Belfrics’ Leveraged Forex Instruments and Crypto Derivative Contracts will be available at http://209.126.0.30/belfricsweb11/Account/Login. 

Belfrics Exchange has plans for rapid expansion. In addition to offering Leveraged Forex Instruments and Crypto Derivative Contracts, it plans to relaunch its cryptocurrency exchange in India in October and open 22 centers in various parts of the country. Belfrics Exchange is a digital asset trading platform that uses a mandated KYC component to identify and verify its users. Belfrics’ proprietary Belrium KYC Verification System is used for KYC identification and verification process for the Belfrics Exchange. Belfrics Exchange currently generates more than $10 million in daily volume by offering 15 crypto pairs to more than 35,000 customers in 12 countries. Belfrics Exchange expects to gain significant market share in the Crypto Derivative market, since there are very few competitors offering the product in the region. In addition to retail interest in Leveraged Forex Instruments and Crypto Derivative Contracts, Belfrics Exchange expects to benefit from pockets of high-volume institutional flows as a result of deep relationships with commodity brokers in many regions. 

Life Clips Inc (OTCMKTS: LCLP) is the parent company of Cognitive Apps Software Solutions Inc. and distributes single-use and cordless batteries under the Mobeego brand for use with cellular phones and other mobile devices. Cognitive Apps is an AI-Powered mental health analytics platform that empowers businesses to measure, understand, and improve mental well-being of their employees, patients and customers. Drug development for mental health disorders and other cognitive impairments is hampered by the inability to identify at risk groups before the onset of clinically significant symptoms, as well as continuous assessments on the progress made by the participants. Cognitive Apps is addressing this problem by pioneering a speech-based AI technology which could help accurately predict risk for various types of depression and mood and anxiety-based disorders years before a clinical diagnosis is obtained. Our technology can help detect and monitor subtle changes in mental state by assessing individuals more frequently and more objectively than the assessments used today. The speech and voice recognition market is expected to grow at a CAGR of 17.2% from 2019 to 2025 to reach $26.79 billion by 2025.  

Microcapdaily first reported on LCLP back on July 20 shortly after the Company had acquired Belfrics Group. The cryptocurrency market is expected to reach $8 trillion dollars by 2030, while the market for blockchain technology is expected to add $176 billion to the US GDP during the same period. Founded in 2014, the Belfrics digital exchange platform, which was fully developed in-house, is one of the most compliant platforms in the cryptocurrency industry. Supported by the proprietary technology of Belrium blockchain KYC solution, the KYC and AML process of Belfrics Exchange is well accepted by regulators globally. With 10 operational offices in 8 countries, Belfrics provides localized and personalized support to digital currency traders. Through its blockchain Academy, Belfrics provides continuous training to traders, developers and blockchain enthusiasts in more than 20 countries. Belfrics is licensed and regulated by the Labuan Financial Services Authority (LFSA) in Malaysia. 

To Find out the inside Scoop on LCLP Subscribe to Microcapdaily.com Right Now by entering your Email in the box below

LCLP

On September 29 LCLP announced its wholly owned subsidiary Belfrics International Limited (Labuan) Malaysia, which holds a money broker license from Labuan Financial Services Authority, will go live offering Leveraged Forex Instruments and Crypto Derivative Contracts to its customers on Saturday, October 2, 2021. Belfrics’ Leveraged Forex Instruments and Crypto Derivative Contracts will be available at http://209.126.0.30/belfricsweb11/Account/Login. 

Belfrics Exchange has plans for rapid expansion. In addition to offering Leveraged Forex Instruments and Crypto Derivative Contracts, it plans to relaunch its cryptocurrency exchange in India in October and open 22 centers in various parts of the country. Belfrics Exchange is a digital asset trading platform that uses a mandated KYC component to identify and verify its users. Belfrics’ proprietary Belrium KYC Verification System is used for KYC identification and verification process for the Belfrics Exchange. Belfrics Exchange currently generates more than $10 million in daily volume by offering 15 crypto pairs to more than 35,000 customers in 12 countries. Belfrics Exchange expects to gain significant market share in the Crypto Derivative market, since there are very few competitors offering the product in the region. In addition to retail interest in Leveraged Forex Instruments and Crypto Derivative Contracts, Belfrics Exchange expects to benefit from pockets of high-volume institutional flows as a result of deep relationships with commodity brokers in many regions. 

Belfrics is seamlessly offering Leveraged Forex Instruments and Crypto Derivative Contracts to its customers through Hybrid Solutions’ VertexFX platform. Hybrid Solutions has been serving forex brokers since 2002 with its VertexFX platform, which features advanced plugins that benefit both retail and institutional traders. The collaboration with Hybrid solutions will ensure a high-quality trading experience for Belfrics Exchange customers as trading volumes increase. Traders will be able to deploy advanced money management tools, copy trading, and auto trading strategies using the VertexFX platform plugins on desktop, web, iOS and Android platforms. 

Akram Majed, CEO of Hybrid Solutions said, “VertexFX Trader provides Belfrics Exchange customers the ability to check all open trades, the market, and pending entry orders through the trade panel in our trading platform. Positions can easily be closed by right-clicking on the position on the trader panel and add a trailing stop, or by double clicking on it. VertexFX Trader also allows users the ability to hedge selected positions, generate reports, and change appearance settings with one click.” Mr. continued, “Hybrid Solutions is grateful for the opportunity to provide Belfrics Exchange and its customers seamless access to Leveraged Forex Instruments and Crypto Derivative Contracts.” 

Belfrics CEO and Founder, Praveen Kumar said, “The Forex Market offers Belfrics Exchange and its customers tremendous opportunities, but the Crypto Derivative market provides our exchange with the opportunity to take significant market share in the space, since there are few players in the space as of yet. Offering access to these markets on our platform gives Belfrics Exchange a tremendous advantage over many of our competitors.” Mr. Kumar continued, “We have set an aggressive goal to achieve over $2 billion in monthly volumes before the end of 2021. As we relaunch our cryptocurrency exchange in India and open 22 centers in various parts of the country next month, we believe our goal is attainable.” 

Robert Grinberg, CEO and President of Life Clips, Inc. said, “We are committed to providing Belfrics Exchange and its customers access to new and innovative products, as well as access to capital for expansion. We believe Belfrics’ plan to introduce leveraged Forex instruments and crypto derivative contracts to its clients is a very timely move. Crypto derivatives have become increasingly more popular among traders, and we expect this piece of the puzzle to spark tremendous growth in Belfrics Exchange.” Mr. Grinberg continued, “We are very excited about the potential for both Belfrics Exchange and Belrium blockchain. We closed our acquisition ahead of schedule and introduced leveraged Forex instruments and crypto derivative contracts as planned. We anticipate announcing additional opportunities related to our acquisition of Belfrics Group in the near future.” 

For more on LCLP Subscribe Right Now!

LCLP is making a powerful move up the charts after the Company reported its wholly owned subsidiary Belfrics International Limited (Labuan) Malaysia, which holds a money broker license from Labuan Financial Services Authority, will go live offering Leveraged Forex Instruments and Crypto Derivative Contracts to its customers on Saturday, October 2, 2021. Belfrics’ Leveraged Forex Instruments and Crypto Derivative Contracts will be available at http://209.126.0.30/belfricsweb11/Account/Login.  Belfrics Exchange has plans for rapid expansion. In addition to offering Leveraged Forex Instruments and Crypto Derivative Contracts, it plans to relaunch its cryptocurrency exchange in India in October and open 22 centers in various parts of the country. Belfrics Exchange is a digital asset trading platform that uses a mandated KYC component to identify and verify its users. Belfrics’ proprietary Belrium KYC Verification System is used for KYC identification and verification process for the Belfrics Exchange. Belfrics Exchange currently generates more than $10 million in daily volume by offering 15 crypto pairs to more than 35,000 customers in 12 countries. Belfrics Exchange expects to gain significant market share in the Crypto Derivative market, since there are very few competitors offering the product in the region. In addition to retail interest in Leveraged Forex Instruments and Crypto Derivative Contracts, Belfrics Exchange expects to benefit from pockets of high-volume institutional flows as a result of deep relationships with commodity brokers in many regions. We wil be updating on LCLP so make sure you Subscribe to Microcapdaily so you know what’s going on with LCLP.

Subscribe to Our 100% Free Penny Stock Newsletter. We Have Something Big Coming!

Disclosure: we hold no position in LCLP either long or short and we have not been compensated for this article.

Emerging Markets

Strong Financials and Social Media Buzz Propel Forza X1, Inc. (NASDAQ:FRZA) to New Heights

Published

on

Forza X1, Inc. (Nasdaq: FRZA) shares witnessed an exceptional and unforeseen surge in its share price, skyrocketing by 151% early morning of June 5th, 2023.

Forza X1, Inc. (Nasdaq: FRZA) shares witnessed an exceptional and unforeseen surge in its share price, skyrocketing by 151% early morning of June 5th, 2023. This surge was accompanied by an unprecedented level of trading volume, marking a significant departure from the previously observed average. Notably, the stock’s trading volume had been relatively low in recent months, with numerous days experiencing trading activity of less than 1,000 shares. Without any apparent news or filings, the cause behind this sudden surge remains a subject of intrigue and speculation among market participants.

What happened?

Firstly it’s important to note that $FRZA is a spin-off of Twin Vee PowerCats Co. (Nasdaq: VEEE). $VEEE is the parent company handling the design, manufacturing, and distribution of recreational and commercial, off-shore power catamaran boats while $FRZA is the new developer of electric sport boats with a mission to accelerate the adoption of sustainable recreational boating.

To Discover the Inside Scoop on FRZA, Subscribe to Microcapdaily.com Right Now by entering your Email in the box below.

Subscribe to Our 100% Free Penny Stock Newsletter. We Have Something Big Coming!

Upon examination of the company, no discernible filings or press releases have been identified to account for today’s remarkable shift. However, it seems that a tweet disseminated by the company caught the attention of retail investors, subsequently generating an enormous surge in trading volume.

This recent occurrence serves as yet another compelling demonstration of the significant impact that the retail community can exert when armed with information regarding a small float micro-cap stock, particularly when the conditions align favorably and validate the potential for substantial gains. The tweet, skillfully crafted by the company’s social media team, featured a compelling GIF and clever “Don’t miss the boat” blurb, demonstrating a keen understanding of their business’s essence. 

The timely and engaging content proved to be a perfect execution, capturing the attention and imagination of investors in a manner that resonated deeply with the nature of the company’s operations.

Overview of Twin Vee PowerCats Co. Financials

Could the surge in share price also reflect the market’s enthusiastic response to Twin Vee’s strong financial results for the first quarter of 2023? 

On May 15, 2023, Twin Vee PowerCats Co. released its financials demonstrating a substantial increase in net revenue and notable improvements in the gas-powered boat segment.

https://twitter.com/JohnZidar/status/1665685698400141313?s=20

Twin Vee PowerCats Co. (Nasdaq: VEEE) reported strong financial results for the first quarter ended March 31, 2023. The company experienced a notable 51% increase in net revenue, reaching $8.9 million compared to $5.9 million in the same period last year. The gas-powered boat segment achieved a net income of $181,000, significantly improving from the net loss of $626,000 in Q1 2022.

However, as per GAAP accounting policy, Twin Vee’s consolidated financial statements resulted in a total net loss of $1.8 million for the quarter, primarily due to their majority ownership in Forza X1, Inc. (Nasdaq: FRZA), an electric boat company. Twin Vee reported cash, cash equivalents, restricted cash, and marketable securities of approximately $12.6 million as of March 31, 2023.

The company has been expanding its product lineup, including introducing the Aquasport mono-hull boat brand. Twin Vee is confident these efforts will contribute to business scalability and brand growth. They aim to optimize inventory levels and production costs while closely monitoring market conditions, dealer inventories, and economic indicators.

Financial highlights for Q1 2023

  • Total revenue: $8,877,000 (51% increase compared to Q1 2022)
  • Gross profit: $3,222,000
  • Net income from gas-powered boats segment: $182,000
  • Net loss from Forza X1 (electric boat entity): $2,005,000
  • Loss from Fix My Boat (franchise business): $5,000
  • Adjusted net loss (excluding non-cash charges): $1,347,000
  • Adjusted net income from gas-powered boats segment: $265,000

Twin Vee’s consolidated cash, cash equivalents, restricted cash, and marketable securities were $23,457,000 as of March 31, 2023. Forza X1 reported $10,683,000 in the same category, while Twin Vee’s core business had $12,643,000, and Fix My Boat had approximately $132,000.

We will closely monitor the performance of Forza X1, Inc. (Nasdaq: FRZA) in the coming weeks, considering that it is a spinoff from its parent company. It is crucial to conduct thorough research, particularly for companies like FRZA that have yet to achieve profitability. However, it is worth noting that the parent company has been making notable progress, as evidenced by its recent financial results, which revealed a substantial increase in the bottom line.

We will update you on FRZA when more details emerge, so make sure you are subscribed to Microcapdaily to know what’s happening in the markets!

Subscribe to Our 100% Free Penny Stock Newsletter. We Have Something Big Coming!

Disclosure: We have not been compensated for this article/video. MicroCap Daily is not an investment advisor; this article/video does not provide investment advice. Always do your research, make your own investment decisions, or consult with your nearest financial advisor. This article/video is not a solicitation or recommendation to buy, sell, or hold securities. This article/video is our opinion, is meant for informational and educational purposes only, and does not provide investment advice. Past performance is not indicative of future performance.

Image by Sasin Tipchai from Pixabay

Continue Reading

Emerging Markets

Aclarion Inc (NASDAQ: ACON): A Breakthrough Partnership

Published

on

Aclarion, Inc. (NASDAQ: ACON) shares rocketed 157% Tuesday morning after their commercialization agreement with the London Clinic.

Aclarion, Inc. (NASDAQ: ACON) shares rocketed 157% Tuesday morning after their commercialization agreement with the London Clinic. The London Clinic is UK’s most renowned independent, private hospital, established 1932 with their Spine Clinic being the first specialist spinal unit based in England back in 1997.

“With a focus on providing the very best healthcare outcomes, The London Clinic is an ideal customer for Aclarion as the company works to deliver the Nociscan solution to physicians and patients around the world,” said John Sutcliffe MD, Neurosurgeon and Founder of London Spine Clinic. “The engagement with Aclarion will allow London Spine Clinic to continue offering the high-quality care our patients have come to expect. Patients need a careful assessment, diagnosis, and understanding of the different treatment options. Aclarion’s innovative Nociscan solution will enable us to objectively assess biomarkers associated with low back pain and enhance the precision of each diagnosis.”

More on Nociscan Technology

Aclarion, Inc.’s Nociscan Technology is an innovative medical solution that aims to revolutionize the diagnosis of disc-related conditions. They leverage biomarkers and proprietary augmented intelligence algorithms to help physicians identify the location of chronic low back pain.

What’s exciting is its advantages over the current standard of care. It offers a non-invasive approach, ensuring patient comfort and safety. Given it’s non-invasive, that also means 0 pain with 0 radiation (typically associated with traditional discography). The best part is it can seamlessly integrate into standard lumbar MRI protocols, making it a convenient and efficient option for healthcare providers. 

To Discover the Inside Scoop on ACON, Subscribe to Microcapdaily.com Right Now by entering your Email in the box below.

Subscribe to Our 100% Free Penny Stock Newsletter. We Have Something Big Coming!

The procedure takes approximately 25-45 minutes, thoroughly evaluating spinal discs without compromising accuracy. Additionally, Nociscan technology offers significant cost savings, with a list price of $1,450, making it an affordable alternative to traditional discograms. Overall, Aclarion, Inc.’s technological advances represent a significant push forward in disc-related diagnostic techniques, prioritizing patient well-being, convenience, and affordability.

https://twitter.com/TigerLineTrades/status/1663527784143093762?s=20

Nociscan Study

They also recently completed a study that spanned two years and involved 78 patients at a single site. The success rate soared to an impressive 85% for patients whose treatment strategy aligned with the disks identified by Nociscan. This represented a remarkable 22% improvement over patients whose treatment strategy did not consider the insights provided by Nociscan.

Aclarion expressed confidence that the results of the trial demonstrate the potential of Nociscan to assist physicians in successfully treating DLBP. Dr. Matthew Gornet, orthopedic surgeon and lead author of the study, enthusiastically endorsed Nociscan, stating, “The two-year surgical outcomes of the clinical trial provide unequivocal evidence of its effectiveness, particularly with regards to the primary endpoint, the Oswestry Disability Index (ODI). I firmly believe that Nociscan has the potential to revolutionize the standard of care and accurately aid all physicians treating chronic low back pain.”

It is worth noting that although Nociscan was performed on all patients in the study, it was not part of the surgical decision-making process, as highlighted by the company.

Conclusion

The commercial agreement between Aclarion, Inc. and the prestigious London Clinic signifies a significant milestone for both parties, carrying the potential for global recognition, revenue growth, and scalability. By integrating Aclarion’s innovative Nociscan Technology, the London Clinic demonstrates its commitment to delivering cutting-edge healthcare to optimize patient well-being and enhance clinical outcomes. Furthermore, the partnership’s success holds the potential for scaling Nociscan Technology to other institutions and markets, propelling Aclarion, Inc. to become a global leader in non-invasive medical technologies while driving substantial revenue growth.

We will update you on ACON when more details emerge, so make sure you are subscribed to Microcapdaily to know what’s happening in the markets!

Subscribe to Our 100% Free Penny Stock Newsletter. We Have Something Big Coming!

Disclosure: We have not been compensated for this article/video. MicroCap Daily is not an investment advisor; this article/video does not provide investment advice. Always do your research, make your own investment decisions, or consult with your nearest financial advisor. This article/video is not a solicitation or recommendation to buy, sell, or hold securities. This article/video is our opinion, is meant for informational and educational purposes only, and does not provide investment advice. Past performance is not indicative of future performance.

Image by PIRO from Pixabay

Continue Reading

Emerging Markets

Aemetis Inc. (NASDAQ: AMTX) Pioneers Renewable Fuel Market with EPA Approval

Published

on

Aemetis (NASDAQ: AMTX) shares surged 105% this week. The renewable natural gas and renewable fuels company received approval from the EPA.

Aemetis, Inc. (NASDAQ: AMTX) shares surged 105% this week. The renewable natural gas and renewable fuels company received approval from the U.S. EPA to generate renewable identification numbers (RINs) under the federal Renewable Fuel Standard. They have six dairy biogas digesters up and running, with a seventh one scheduled to start operating in June 2023.

Aemetis plans to generate multiple sources of revenue from its renewable natural gas. They will sell the gas to replace petroleum diesel in transportation, sell California Low Carbon Fuel Standard credits to fuel blenders who need to meet carbon reduction requirements in California, sell the RINs generated under the federal Renewable Fuel Standard, and benefit from production tax credits starting in 2025 under the Inflation Reduction Act.

They have completed constructing and operating six dairy digesters, a biogas pipeline spanning over 40 miles, a central facility to upgrade biogas to renewable natural gas, and a utility pipeline interconnection unit. The renewable natural gas is injected into the utility gas system and stored underground until Aemetis Biogas obtains carbon intensity (CI) pathway approvals from the California Air Resources Board (CARB) to sell credits under the California Low Carbon Fuel Standard.

They have already completed 90 days of renewable natural gas production and data collection required for the CARB approval process. While the final pathway is under review by CARB, Aemetis can use a temporary CI pathway with a value of -150, allowing them to start generating revenue in the third quarter of 2023.

To Discover the Inside Scoop on AMTX, Subscribe to Microcapdaily.com Right Now by entering your Email in the box below.

Subscribe to Our 100% Free Penny Stock Newsletter. We Have Something Big Coming!

Andy Foster, the president of Aemetis Biogas Inc., expressed excitement about the approval of Aemetis Biogas for generating D3 RINs, as it marks a significant milestone towards generating full product revenue. He emphasized that the company’s investments since 2019 have directly reduced greenhouse gas pollution, improved air quality in Central Valley communities, and created jobs. Aemetis is committed to expanding their network of dairy digesters and producing more carbon-negative renewable natural gas to replace petroleum diesel.

The dairy digesters, pipeline project, and biogas-to-RNG facility funding includes grants from the California Department of Food and Agriculture and the California Energy Commission. Aemetis also closed a $25 million long-term financing deal with Greater Commercial Lending last fall, supported by a loan guarantee from the USDA. This project financing has a low fixed interest rate for the first five years and spans over 20 years.

Aemetis has plans to file applications for an additional $100 million of loans from the USDA’s REAP loan program. These funds will support the engineering, permitting, and construction of 31 more dairies. Each loan application will be limited to a maximum of $25 million and carry a 20-year repayment term.

https://twitter.com/Theweedfarmer/status/1658946668052504576?s=20

Where could Aemetis, Inc. (NASDAQ: AMTX) be in 5 years?

The company has an ambitious Five Year Plan to generate substantial revenue and reduce air and carbon pollution. The plan projects $2.0 billion in revenues, $496 million in net income, and $682 million in adjusted EBITDA by 2027, with strong compound annual growth rates. Aemetis aims to expand its operations by producing Renewable Natural Gas (RNG), Sustainable Aviation Fuel (SAF), Renewable Diesel fuel (RD), and other low-carbon products. The plan emphasizes the positive financial impact of the Inflation Reduction Act.

The plan highlights the financial benefits of the Inflation Reduction Act, which enables the transfer of tax credits and incentives related to production, projected to improve net income by $341 million in 2027.

The plan also focuses on revenue growth in all product lines, including expanding the dairy RNG business, constructing a renewable jet/diesel plant, implementing carbon sequestration, and improving energy efficiencies. 

The company has already achieved significant milestones, such as completing biogas pipeline construction, upgrading facilities for biogas-to-RNG production, and progressing in carbon sequestration and renewable jet/diesel plant development. The company has also secured a biodiesel purchase agreement in India and made strides in constructing a solar microgrid and implementing energy-efficient measures.

We will update you on AMTX when more details emerge, so make sure you are subscribed to Microcapdaily to know what’s happening in the markets!

Subscribe to Our 100% Free Penny Stock Newsletter. We Have Something Big Coming!

Disclosure: We have not been compensated for this article/video. MicroCap Daily is not an investment advisor; this article/video does not provide investment advice. Always do your research, make your own investment decisions, or consult with your nearest financial advisor. This article/video is not a solicitation or recommendation to buy, sell, or hold securities. This article/video is our opinion, is meant for informational and educational purposes only, and does not provide investment advice. Past performance is not indicative of future performance.

Image by Leopold Böttcher from Pixabay

Continue Reading

Trending

© All rights reserved.

Sign up now for our 100% FREE Penny Stock Newsletter

Privacy Policy. we will never share your email with anyone.